Chapter 19. Management of Tuberculosis

  1. Anthony Seaton CBE, BA, MD, FRCP, FRCPE, FFOM, FMedSci1,2,
  2. Douglas Seaton MD, FRCP3 and
  3. The late A. Gordon Leitch Bsc, MB, PhD, FRCPE, FCCP
  1. A. Gordon Leitch

Published Online: 16 APR 2008

DOI: 10.1002/9780470695999.ch19

Crofton and Douglas's Respiratory Diseases, Fifth Edition

Crofton and Douglas's Respiratory Diseases, Fifth Edition

How to Cite

Leitch, A. G. (2000) Management of Tuberculosis, in Crofton and Douglas's Respiratory Diseases, Fifth Edition (eds A. Seaton, D. Seaton and A. G. Leitch), Blackwell Science Ltd, Oxford, UK. doi: 10.1002/9780470695999.ch19

Editor Information

  1. 1

    Professor of Environmental & Occupational Medicine, University of Aberdeen, Scotland

  2. 2

    Honorary Consultant Physician, Aberdeen Royal Hospital NHS Trust

  3. 3

    Consultant Physician, Department of Respiratory Medicine, The Ipswich Hospital NHS Trust, Suffolk, England

Publication History

  1. Published Online: 16 APR 2008
  2. Published Print: 1 JAN 2000

ISBN Information

Print ISBN: 9780865428577

Online ISBN: 9780470695999



  • tuberculosis;
  • lesions;
  • pneumothorax;
  • pneumoperitoneum;
  • thoracoplasty


This chapter contains section titled:

  • Rationale of Short-Course Chemotherapy

  • Antituberculosis Drugs

  • Generalized Reactions to Antituberculosis Drugs

  • Chemotherapy Regimens for Pulmonary Tuberculosis

  • Chemotherapy Regimens for Extrapulmonary Tuberculosis

  • Chemotherapy Regimens for Primary Tuberculosis

  • Treatment in Other Special Situations

  • Drug Resistance and the Management of Disease Due to Drug-Resistant Organisms

  • Corticosteroid Therapy in Tuberculosis

  • References